Updates are available Correction dated 2020-12-15
Click to view Correction: https://doi.org/10.1038/s41593-020-00774-5
-
Authors
Joshi, Amit U. https://orcid.org/0000-0002-2472-7672
Minhas, Paras S.
Liddelow, Shane A. https://orcid.org/0000-0002-0840-1437
Haileselassie, Bereketeab
Andreasson, Katrin I. https://orcid.org/0000-0001-8391-4155
Dorn, Gerald W. II
Mochly-Rosen, Daria https://orcid.org/0000-0002-6691-8733
-
Funding
Funding for this research was provided by:
Paul and Daisy Soros Fellowships for New Americans
Glenn Foundation for Medical Research
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG058047)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL135736, HL52141)
Stanford Discovery Innovation Grant
- License Information
-
More Information
Article History
Received: 14 August 2018
Accepted: 5 August 2019
First Online: 23 September 2019
Change Date: 15 December 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41593-020-00774-5
Change Date: 23 February 2024
Change Type: Clarification
Change Details: Editor's Note: Readers are alerted that concerns have been raised about the data and statistical analysis reported in this article. Further editorial action will be taken if appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.
Competing interests
: Patents on P110 and its utility in HD, ALS and other neurodegenerative diseases have been filed by D.M.‐R. and A.U.J. The other authors declare no competing interests.
